You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

darolutamide

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Darolutamide
  • Docetaxel or cabazitaxel
  • (no location specified)
Feb 28, 2023

Prostate Cancer Trial in Worldwide (AZD5305, Darolutamide, No Treatment)

Not yet recruiting
  • Prostate Cancer
  • Melbourne, Australia
  • +7 more
Jul 3, 2023

Darolutamide, Enzalutamide and Apalutamide and How Well These

Not yet recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Whippany, New Jersey
    Bayer
Aug 25, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Prostate Cancer Trial in Beijing (Darolutamide+ADT)

Not yet recruiting
  • Prostate Cancer
  • Beijing, China
    Peking University First Hospital
Sep 1, 2023

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

Not yet recruiting
  • Prostate Cancer
  • Darolutamide Oral Tablet [Nubeqa]
  • (no location specified)
Jun 2, 2023

Learn More About How Safe Darolutamide is Under Real-world

Not yet recruiting
  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
  • No Intervention
  • Multiple Locations, Japan
    Many Locations
Aug 24, 2023

Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed

Recruiting
  • Prostate Cancer
  • +4 more
  • Darolutamide
  • metastasis-directed treatment
  • Aalst, Belgium
  • +6 more
Jan 25, 2023

Prostate Cancer Trial in France (Surgery alone, Peri-operative darolutamide + surgery.)

Not yet recruiting
  • Prostate Cancer
  • Surgery alone
  • Peri-operative darolutamide + surgery.
  • Angers, France
  • +10 more
Apr 12, 2023

Called DEAR, to Learn More About Treatment With Darolutamide,

Active, not recruiting
  • Non-metastatic Castration-resistant Prostate Cancer
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Whippany, New Jersey
    Bayer
Jan 13, 2023

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Darolutamide
  • +4 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial (Standard ADT (androgen deprivation therapy), Standard Darolutamide,

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • Standard ADT (androgen deprivation therapy)
  • +2 more
  • (no location specified)
Jan 6, 2023

Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)

Recruiting
  • Prostate Cancer
  • Testosterone Cypionate
  • Darolutamide
  • Brasília, Distrito Federal, Brazil
  • +4 more
Dec 22, 2022

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Mineola, New York
  • +14 more
Aug 23, 2023

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Prostate Cancer Trial in Multiple Locations (Darolutamide 600 mg twice daily, Placebo 600 mg twice daily, Androgen deprivation

Recruiting
  • Prostate Cancer
  • Darolutamide 600 mg twice daily
  • +2 more
  • Multiple Locations, China
    Many Locations
Aug 2, 2022

Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

Recruiting
  • Castrate Resistant Prostate Cancer
  • Chicago, Illinois
  • +2 more
Jul 19, 2022

Prostate Cancer Trial (Darolutamide 300 mg, Placebo of Darolutamide)

Not yet recruiting
  • Prostate Cancer
  • Darolutamide 300 mg
  • Placebo of Darolutamide
  • (no location specified)
Feb 10, 2022

Prostatic Cancer, Castration-Resistant Trial in United States (Darolutamide(Nubeqa, BAY1841788), Enzalutamide)

Completed
  • Prostatic Cancer, Castration-Resistant
  • Portland, Maine
  • +6 more
Aug 18, 2022

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)

Recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • ADT
  • Homewood, Alabama
  • +11 more
Jan 13, 2023

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Prostate Cancer Trial in Nanning (Darolutamide 300 mg, Androgen deprivation therapy)

Not yet recruiting
  • Prostate Cancer
  • Darolutamide 300 mg
  • Androgen deprivation therapy
  • Nanning, Jiangsu, China
    Hongqian Guo
Feb 19, 2022

Prostate Cancer Trial in France (Association of darolutamide and EBRT, Association of ADT and EBRT)

Not yet recruiting
  • Prostate Cancer
  • Association of darolutamide and EBRT
  • Association of ADT and EBRT
  • Avignon, France
  • +9 more
Apr 21, 2022